Annual Gross Profit
$34.19 B
+$2.31 B+7.24%
31 December 2023
Summary:
Novartis AG annual gross profit is currently $34.19 billion, with the most recent change of +$2.31 billion (+7.24%) on 31 December 2023. During the last 3 years, it has fallen by -$589.00 million (-1.69%). NVS annual gross profit is now -15.36% below its all-time high of $40.39 billion, reached on 31 December 2011.NVS Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Gross Profit
$9.94 B
+$239.00 M+2.46%
30 September 2024
Summary:
Novartis AG quarterly gross profit is currently $9.94 billion, with the most recent change of +$239.00 million (+2.46%) on 30 September 2024. Over the past year, it has increased by +$963.00 million (+10.73%). NVS quarterly gross profit is now -5.39% below its all-time high of $10.50 billion, reached on 30 June 2011.NVS Quarterly Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Gross Profit
$37.41 B
+$963.00 M+2.64%
30 September 2024
Summary:
Novartis AG TTM gross profit is currently $37.41 billion, with the most recent change of +$963.00 million (+2.64%) on 30 September 2024. Over the past year, it has increased by +$4.06 billion (+12.16%). NVS TTM gross profit is now -7.51% below its all-time high of $40.45 billion, reached on 30 September 2011.NVS TTM Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NVS Gross Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +7.2% | +10.7% | +12.2% |
| 3 y3 years | -1.7% | +5.4% | +3.1% |
| 5 y5 years | +8.2% | +14.2% | +12.1% |
NVS Gross Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -1.7% | +7.2% | at high | +108.1% | at high | +20.8% |
| 5 y | 5 years | -1.7% | +8.2% | at high | +108.1% | at high | +20.8% |
| alltime | all time | -15.4% | +143.9% | -5.4% | +208.6% | -7.5% | +1062.0% |
Novartis AG Gross Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $9.94 B(+2.5%) | $37.41 B(+2.6%) |
| June 2024 | - | $9.70 B(+7.5%) | $36.45 B(+3.7%) |
| Mar 2024 | - | $9.02 B(+3.1%) | $35.16 B(+2.8%) |
| Dec 2023 | $34.19 B(+7.2%) | $8.75 B(-2.5%) | $34.19 B(+2.5%) |
| Sept 2023 | - | $8.97 B(+6.8%) | $33.36 B(+3.3%) |
| June 2023 | - | $8.40 B(+4.3%) | $32.29 B(-2.8%) |
| Mar 2023 | - | $8.06 B(+1.7%) | $33.22 B(-2.6%) |
| Dec 2022 | $31.88 B(-1.1%) | $7.92 B(+0.2%) | $34.13 B(+10.2%) |
| Sept 2022 | - | $7.91 B(-15.3%) | $30.98 B(-4.7%) |
| June 2022 | - | $9.33 B(+4.2%) | $32.50 B(-0.1%) |
| Mar 2022 | - | $8.96 B(+87.6%) | $32.54 B(+0.9%) |
| Dec 2021 | $32.24 B(-7.3%) | $4.78 B(-49.4%) | $32.24 B(-11.1%) |
| Sept 2021 | - | $9.43 B(+0.5%) | $36.28 B(+1.8%) |
| June 2021 | - | $9.38 B(+8.4%) | $35.63 B(+3.4%) |
| Mar 2021 | - | $8.65 B(-1.8%) | $34.45 B(-1.0%) |
| Dec 2020 | $34.78 B(+1.5%) | $8.81 B(+0.3%) | $34.78 B(+0.3%) |
| Sept 2020 | - | $8.79 B(+7.2%) | $34.69 B(+0.2%) |
| June 2020 | - | $8.19 B(-8.8%) | $34.61 B(-1.2%) |
| Mar 2020 | - | $8.99 B(+3.0%) | $35.03 B(+2.3%) |
| Dec 2019 | $34.25 B(+8.4%) | $8.72 B(+0.2%) | $34.25 B(+2.6%) |
| Sept 2019 | - | $8.71 B(+1.0%) | $33.39 B(+2.4%) |
| June 2019 | - | $8.62 B(+5.0%) | $32.60 B(+1.6%) |
| Mar 2019 | - | $8.20 B(+4.4%) | $32.08 B(+1.6%) |
| Dec 2018 | $31.59 B(+6.1%) | $7.86 B(-0.8%) | $31.59 B(+8.1%) |
| Sept 2018 | - | $7.92 B(-2.1%) | $29.22 B(-1.5%) |
| June 2018 | - | $8.10 B(+5.0%) | $29.66 B(-0.5%) |
| Mar 2018 | - | $7.71 B(+40.6%) | $29.80 B(+0.1%) |
| Dec 2017 | $29.77 B(-6.7%) | $5.49 B(-34.4%) | $29.77 B(-8.1%) |
| Sept 2017 | - | $8.37 B(+1.6%) | $32.40 B(+1.2%) |
| June 2017 | - | $8.24 B(+7.2%) | $32.01 B(+0.0%) |
| Mar 2017 | - | $7.68 B(-5.4%) | $32.00 B(+0.3%) |
| Dec 2016 | $31.92 B(-3.2%) | $8.12 B(+1.8%) | $31.92 B(-0.4%) |
| Sept 2016 | - | $7.97 B(-3.1%) | $32.05 B(-0.4%) |
| June 2016 | - | $8.23 B(+8.3%) | $32.18 B(-0.6%) |
| Mar 2016 | - | $7.60 B(-8.0%) | $32.36 B(-1.9%) |
| Dec 2015 | $32.98 B(-9.1%) | $8.26 B(+2.0%) | $32.98 B(-2.0%) |
| Sept 2015 | - | $8.10 B(-3.7%) | $33.67 B(-2.3%) |
| June 2015 | - | $8.41 B(+2.3%) | $34.45 B(-3.3%) |
| Mar 2015 | - | $8.22 B(-8.0%) | $35.61 B(-1.9%) |
| Dec 2014 | $36.29 B(+0.4%) | $8.94 B(+0.7%) | $36.29 B(-0.7%) |
| Sept 2014 | - | $8.88 B(-7.2%) | $36.55 B(+0.3%) |
| June 2014 | - | $9.57 B(+7.5%) | $36.45 B(+1.0%) |
| Mar 2014 | - | $8.90 B(-3.3%) | $36.07 B(-1.9%) |
| Dec 2013 | $36.14 B(+0.1%) | $9.20 B(+4.8%) | $36.77 B(+5.5%) |
| Sept 2013 | - | $8.78 B(-4.5%) | $34.85 B(-1.9%) |
| June 2013 | - | $9.19 B(-4.2%) | $35.54 B(-2.0%) |
| Mar 2013 | - | $9.60 B(+31.9%) | $36.28 B(+0.5%) |
| Dec 2012 | $36.10 B | $7.28 B(-23.1%) | $36.10 B(-6.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2012 | - | $9.46 B(-4.7%) | $38.70 B(-2.0%) |
| June 2012 | - | $9.93 B(+5.3%) | $39.48 B(-1.4%) |
| Mar 2012 | - | $9.43 B(-4.5%) | $40.06 B(-0.8%) |
| Dec 2011 | $40.39 B(+9.0%) | $9.88 B(-3.6%) | $40.39 B(-0.2%) |
| Sept 2011 | - | $10.25 B(-2.5%) | $40.45 B(+2.8%) |
| June 2011 | - | $10.50 B(+7.6%) | $39.37 B(+4.8%) |
| Mar 2011 | - | $9.76 B(-1.8%) | $37.58 B(+1.4%) |
| Dec 2010 | $37.07 B(+12.6%) | $9.94 B(+8.5%) | $37.07 B(+1.3%) |
| Sept 2010 | - | $9.16 B(+5.1%) | $36.61 B(+2.7%) |
| June 2010 | - | $8.71 B(-5.9%) | $35.64 B(+2.3%) |
| Mar 2010 | - | $9.26 B(-2.3%) | $34.84 B(+6.6%) |
| Dec 2009 | $32.92 B(+5.7%) | $9.48 B(+15.8%) | $32.70 B(+6.4%) |
| Sept 2009 | - | $8.19 B(+3.4%) | $30.74 B(+0.6%) |
| June 2009 | - | $7.92 B(+11.2%) | $30.56 B(-0.4%) |
| Mar 2009 | - | $7.12 B(-5.3%) | $30.70 B(-1.4%) |
| Dec 2008 | $31.14 B(+11.6%) | $7.51 B(-6.2%) | $31.14 B(+1.2%) |
| Sept 2008 | - | $8.01 B(-0.6%) | $30.79 B(+4.1%) |
| June 2008 | - | $8.05 B(+6.4%) | $29.56 B(+4.1%) |
| Mar 2008 | - | $7.57 B(+5.7%) | $28.41 B(+2.5%) |
| Dec 2007 | $27.91 B(+8.6%) | $7.16 B(+5.5%) | $27.73 B(+0.7%) |
| Sept 2007 | - | $6.78 B(-1.7%) | $27.55 B(+1.1%) |
| June 2007 | - | $6.90 B(+0.2%) | $27.26 B(+2.3%) |
| Mar 2007 | - | $6.89 B(-1.3%) | $26.64 B(+3.6%) |
| Dec 2006 | $25.69 B(+15.1%) | $6.98 B(+7.4%) | $25.72 B(+8.8%) |
| Sept 2006 | - | $6.50 B(+3.4%) | $23.64 B(+2.0%) |
| June 2006 | - | $6.28 B(+5.3%) | $23.18 B(+1.7%) |
| Mar 2006 | - | $5.97 B(+22.0%) | $22.79 B(+2.2%) |
| Dec 2005 | $22.31 B(+8.4%) | $4.89 B(-19.0%) | $22.31 B(+1.1%) |
| Sept 2005 | - | $6.04 B(+2.4%) | $22.07 B(+2.8%) |
| June 2005 | - | $5.89 B(+7.4%) | $21.48 B(+2.5%) |
| Mar 2005 | - | $5.49 B(+18.0%) | $20.96 B(+1.9%) |
| Dec 2004 | $20.58 B(+11.4%) | $4.65 B(-14.6%) | $20.58 B(+0.1%) |
| Sept 2004 | - | $5.44 B(+1.2%) | $20.55 B(+3.7%) |
| June 2004 | - | $5.38 B(+5.4%) | $19.82 B(+3.1%) |
| Mar 2004 | - | $5.10 B(+10.3%) | $19.22 B(+4.0%) |
| Dec 2003 | $18.47 B(+16.3%) | $4.63 B(-1.8%) | $18.47 B(+2.3%) |
| Sept 2003 | - | $4.71 B(-1.5%) | $18.07 B(+5.0%) |
| June 2003 | - | $4.78 B(+9.7%) | $17.20 B(+2.9%) |
| Mar 2003 | - | $4.36 B(+3.3%) | $16.73 B(+35.2%) |
| Dec 2002 | $15.88 B(+13.3%) | $4.22 B(+9.6%) | $12.37 B(+51.8%) |
| Sept 2002 | - | $3.85 B(-10.5%) | $8.15 B(+89.5%) |
| June 2002 | - | $4.30 B(+32.3%) | $4.30 B(+32.3%) |
| Dec 2001 | $14.02 B(-11.5%) | - | - |
| June 2001 | - | $3.25 B(+1.0%) | $3.25 B(+1.0%) |
| Dec 2000 | $15.84 B(+4.4%) | - | - |
| June 2000 | - | $3.22 B | $3.22 B |
| Dec 1999 | $15.16 B(-3.6%) | - | - |
| Dec 1998 | $15.73 B | - | - |
FAQ
- What is Novartis AG annual gross profit?
- What is the all time high annual gross profit for Novartis AG?
- What is Novartis AG annual gross profit year-on-year change?
- What is Novartis AG quarterly gross profit?
- What is the all time high quarterly gross profit for Novartis AG?
- What is Novartis AG quarterly gross profit year-on-year change?
- What is Novartis AG TTM gross profit?
- What is the all time high TTM gross profit for Novartis AG?
- What is Novartis AG TTM gross profit year-on-year change?
What is Novartis AG annual gross profit?
The current annual gross profit of NVS is $34.19 B
What is the all time high annual gross profit for Novartis AG?
Novartis AG all-time high annual gross profit is $40.39 B
What is Novartis AG annual gross profit year-on-year change?
Over the past year, NVS annual gross profit has changed by +$2.31 B (+7.24%)
What is Novartis AG quarterly gross profit?
The current quarterly gross profit of NVS is $9.94 B
What is the all time high quarterly gross profit for Novartis AG?
Novartis AG all-time high quarterly gross profit is $10.50 B
What is Novartis AG quarterly gross profit year-on-year change?
Over the past year, NVS quarterly gross profit has changed by +$963.00 M (+10.73%)
What is Novartis AG TTM gross profit?
The current TTM gross profit of NVS is $37.41 B
What is the all time high TTM gross profit for Novartis AG?
Novartis AG all-time high TTM gross profit is $40.45 B
What is Novartis AG TTM gross profit year-on-year change?
Over the past year, NVS TTM gross profit has changed by +$4.06 B (+12.16%)